CN107184559A - 一种盐酸二甲双胍缓释片及其制备方法 - Google Patents
一种盐酸二甲双胍缓释片及其制备方法 Download PDFInfo
- Publication number
- CN107184559A CN107184559A CN201710407540.5A CN201710407540A CN107184559A CN 107184559 A CN107184559 A CN 107184559A CN 201710407540 A CN201710407540 A CN 201710407540A CN 107184559 A CN107184559 A CN 107184559A
- Authority
- CN
- China
- Prior art keywords
- release
- sustained
- hydroxypropyl methylcellulose
- diabecron sustained
- release tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
时间(h) | 1 | 2 | 4 | 6 | 8 | 10 | 12 |
实施例1 | 12% | 28% | 46% | 63% | 74% | 84% | 95% |
实施例2 | 14% | 32% | 51% | 67% | 78% | 89% | 99% |
实施例3 | 10% | 25% | 43% | 60% | 69% | 79% | 90% |
实施例4 | 13% | 27% | 47% | 62% | 75% | 86% | 97% |
实施例5 | 13% | 27% | 42% | 64% | 74% | 85% | 96% |
对比例1 | 20% | 38% | 54% | 76% | 86% | 96% | 99% |
对比例2 | 23% | 40% | 55% | 79% | 88% | 98% | 99% |
对比例3 | 37% | 54% | 71% | 84% | 93% | 99% | 99% |
对比例4 | 30% | 47% | 65% | 80% | 95% | 98% | 99% |
对比例5 | 18% | 34% | 45% | 72% | 81% | 94% | 97% |
对比例6 | 19% | 32% | 50% | 75% | 83% | 95% | 98% |
对比例7 | 22% | 40% | 55% | 78% | 90% | 96% | 99% |
对比例8 | 35% | 52% | 70% | 82% | 94% | 98% | 100% |
上市产品 | 28% | 43% | 65% | 76% | 88% | 95% | 96% |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710407540.5A CN107184559B (zh) | 2017-06-02 | 2017-06-02 | 一种盐酸二甲双胍缓释片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710407540.5A CN107184559B (zh) | 2017-06-02 | 2017-06-02 | 一种盐酸二甲双胍缓释片及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107184559A true CN107184559A (zh) | 2017-09-22 |
CN107184559B CN107184559B (zh) | 2018-07-31 |
Family
ID=59877014
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710407540.5A Active CN107184559B (zh) | 2017-06-02 | 2017-06-02 | 一种盐酸二甲双胍缓释片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107184559B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112336739A (zh) * | 2020-05-27 | 2021-02-09 | 广东赛康药业有限公司 | 一种盐酸二甲双胍与甲钴胺的药物组合物及其制备方法 |
CN113057947A (zh) * | 2021-04-01 | 2021-07-02 | 广东赛康制药厂有限公司 | 一种低ndma、小骨架盐酸二甲双胍缓释片及制备方法 |
CN113081973A (zh) * | 2021-05-07 | 2021-07-09 | 郑州泰丰制药有限公司 | 一种盐酸二甲双胍组合物及其制备方法 |
CN114404376A (zh) * | 2022-03-16 | 2022-04-29 | 成都恒瑞制药有限公司 | 一种盐酸二甲双胍缓释片剂及其制备方法 |
CN114948891A (zh) * | 2021-06-07 | 2022-08-30 | 南通联亚药业股份有限公司 | 药物组合物 |
WO2022184981A1 (en) * | 2021-03-03 | 2022-09-09 | Orion Corporation | Stable pharmaceutical compositions of metformin |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110354090B (zh) * | 2019-07-29 | 2021-10-01 | 石药集团欧意药业有限公司 | 一种盐酸二甲双胍缓释片及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1635894A (zh) * | 2001-09-28 | 2005-07-06 | 太阳医药工业有限公司 | 糖尿病治疗剂型 |
TWI248815B (en) * | 2003-11-05 | 2006-02-11 | Pei Li Pharmaceutical Ind Co L | The controlled release formulation of metformin HCl |
CN101951891A (zh) * | 2008-01-11 | 2011-01-19 | 希普拉有限公司 | 固态药物剂型 |
CN102247343A (zh) * | 2011-05-18 | 2011-11-23 | 四川晖瑞医药科技有限公司 | 一种复方吡格列酮二甲双胍缓释片制备工艺 |
-
2017
- 2017-06-02 CN CN201710407540.5A patent/CN107184559B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1635894A (zh) * | 2001-09-28 | 2005-07-06 | 太阳医药工业有限公司 | 糖尿病治疗剂型 |
TWI248815B (en) * | 2003-11-05 | 2006-02-11 | Pei Li Pharmaceutical Ind Co L | The controlled release formulation of metformin HCl |
CN101951891A (zh) * | 2008-01-11 | 2011-01-19 | 希普拉有限公司 | 固态药物剂型 |
CN102247343A (zh) * | 2011-05-18 | 2011-11-23 | 四川晖瑞医药科技有限公司 | 一种复方吡格列酮二甲双胍缓释片制备工艺 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112336739A (zh) * | 2020-05-27 | 2021-02-09 | 广东赛康药业有限公司 | 一种盐酸二甲双胍与甲钴胺的药物组合物及其制备方法 |
WO2022184981A1 (en) * | 2021-03-03 | 2022-09-09 | Orion Corporation | Stable pharmaceutical compositions of metformin |
CN113057947A (zh) * | 2021-04-01 | 2021-07-02 | 广东赛康制药厂有限公司 | 一种低ndma、小骨架盐酸二甲双胍缓释片及制备方法 |
CN113081973A (zh) * | 2021-05-07 | 2021-07-09 | 郑州泰丰制药有限公司 | 一种盐酸二甲双胍组合物及其制备方法 |
CN114948891A (zh) * | 2021-06-07 | 2022-08-30 | 南通联亚药业股份有限公司 | 药物组合物 |
CN114404376A (zh) * | 2022-03-16 | 2022-04-29 | 成都恒瑞制药有限公司 | 一种盐酸二甲双胍缓释片剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN107184559B (zh) | 2018-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107184559B (zh) | 一种盐酸二甲双胍缓释片及其制备方法 | |
CN1635894A (zh) | 糖尿病治疗剂型 | |
WO2022012172A1 (zh) | 一种难溶性药物口服缓释组合物及其制备方法 | |
CN103479592B (zh) | 一种盐酸二甲双胍缓释片及其制备方法 | |
CN107669683B (zh) | 含有西格列汀与二甲双胍的药物组合物 | |
CN103520128B (zh) | 一种普拉克索的缓释片剂、制备方法及其用途 | |
CN101851247B (zh) | 含有硫酸氢氯吡格雷晶体颗粒的组合物 | |
CN105853383A (zh) | 一种治疗糖尿病性神经病变的药物组合物及其制备方法 | |
CN105434386B (zh) | 一种含有高水溶性活性成分的缓释片剂及其制备方法 | |
CN105496966A (zh) | 一种恩格列净固体分散体的药物组合物及其制备方法 | |
CN102028662B (zh) | 苯磺酸左旋氨氯地平片及其制备及有关物质的控制方法 | |
CN110585155A (zh) | 一种格列齐特片(ii)及其制备方法 | |
CN102379855A (zh) | 格列美脲分散片及其制备方法 | |
CN105362243B (zh) | 硫酸氢氯吡格雷口服固体药物组合物及其制备方法 | |
EP3965739B1 (en) | Tablet dosage formulations of oleyl phosphocholine | |
CN111450069A (zh) | 一种盐酸二甲双胍口服缓释片剂及其制备方法 | |
CN103877038A (zh) | 一种羟苯磺酸钙分散片及其制备方法 | |
CN102525981B (zh) | 一种盐酸普萘洛尔片及其制备方法 | |
CN112618501A (zh) | 一种伏格列波糖片剂及其制备方法 | |
CN109330995A (zh) | 一种包载短效降糖药的微丸及其制备方法 | |
CN115177593B (zh) | 一种谷氨酰胺颗粒剂及其制备方法 | |
CN113855648B (zh) | 一种乙酰唑胺缓释胶囊及其制备方法 | |
CN115245495B (zh) | 一种西格列汀二甲双胍片及其制备方法 | |
CN112516099B (zh) | 一种格列齐特缓释片及其制备方法 | |
CN107929250A (zh) | 一种洛氟普啶片剂组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190424 Address after: 510000 Building 601, B5, 11 Kaiyuan Avenue, Science City, East District, Huangpu District, Guangzhou City, Guangdong Province Co-patentee after: Saikang (Guangzhou) Pharmaceutical Co.,Ltd. Patentee after: Guangdong Saikang Pharmaceutical Co.,Ltd. Co-patentee after: GUANGDONG SINOCORP PHARMACEUTICAL FACTORY CO.,LTD. Address before: 516800 Xiang2 Road, Huizhou Industrial Transfer Park, Huizhou City, Guangdong Province Patentee before: GUANGDONG SINOCORP PHARMACEUTICAL FACTORY CO.,LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220307 Address after: 510000 Building 601, B5, 11 Kaiyuan Avenue, Science City, East District, Huangpu District, Guangzhou City, Guangdong Province Patentee after: Guangdong Saikang Pharmaceutical Co.,Ltd. Patentee after: GUANGDONG SINOCORP PHARMACEUTICAL FACTORY CO.,LTD. Address before: 510000 Building 601, B5, 11 Kaiyuan Avenue, Science City, East District, Huangpu District, Guangzhou City, Guangdong Province Patentee before: Guangdong Saikang Pharmaceutical Co.,Ltd. Patentee before: Saikang (Guangzhou) Pharmaceutical Co.,Ltd. Patentee before: GUANGDONG SINOCORP PHARMACEUTICAL FACTORY CO.,LTD. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: Room 01 and Room 02 (for office use only), Room 1701, No. 31, Tianshou Road, Tianhe District, Guangzhou, Guangdong 510000 Patentee after: Guangdong Saikang Pharmaceutical Co.,Ltd. Patentee after: GUANGDONG SINOCORP PHARMACEUTICAL FACTORY CO.,LTD. Address before: 510000 Building 601, B5, 11 Kaiyuan Avenue, Science City, East District, Huangpu District, Guangzhou City, Guangdong Province Patentee before: Guangdong Saikang Pharmaceutical Co.,Ltd. Patentee before: GUANGDONG SINOCORP PHARMACEUTICAL FACTORY CO.,LTD. |